TY - JOUR
T1 - Metabolic syndrome and the benefit of a physical activity intervention on lower-extremity function
T2 - Results from a randomized clinical trial
AU - Botoseneanu, Anda
AU - Chen, Haiying
AU - Ambrosius, Walter T.
AU - Allore, Heather G.
AU - Anton, Stephen
AU - Folta, Sara C.
AU - King, Abby C.
AU - Nicklas, Barbara J.
AU - Spring, Bonnie
AU - Strotmeyer, Elsa S.
AU - Gill, Thomas M.
N1 - Funding Information:
Dr. Gill is supported by the Yale Claude D. Pepper Older Americans Independence Center ( P30AG21342 ).
Funding Information:
Dr. Botoseneanu was funded by grants AG024824 from the University of Michigan - Claude D. Pepper Older Americans Independence Center; UL1TR000433 from the Michigan Institute for Clinical and Health Research .
Funding Information:
The LIFE Study is funded by a National Institutes of Health / National Institute on Aging Cooperative Agreement U01AG22376 and a supplement from the National Heart, Lung and Blood Institute (3U01AG022376). It is sponsored in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health . Complete acknowledgments and funding information are shown in Supplementary Text S3 and are available at: https://www.thelifestudy.org/secure/documents .
Publisher Copyright:
© 2021
PY - 2021/7/15
Y1 - 2021/7/15
N2 - Background: In older adults, increases in physical activity may prevent decline in lower-extremity function, but whether the benefit differs according to metabolic syndrome (MetS) status is uncertain. We aim to investigate whether structured physical activity is associated with less decline in lower-extremity function among older adults with versus without MetS. Methods: We used data from the multicenter Lifestyle Interventions and Independence for Elders (LIFE) study to analyze 1535 sedentary functionally-vulnerable women and men, aged 70 to 89 years old, assessed every 6 months (February 2010–December 2013) for an average of 2.7 years. Participants were randomized to a structured, moderate-intensity physical activity intervention (PA; n = 766) or health education program (HE; n = 769). MetS was defined according to the 2009 multi-agency harmonized criteria. Lower-extremity function was assessed by 400-m walking speed and the Short Physical Performance Battery (SPPB) score. Results: 763 (49.7%) participants met criteria for MetS at baseline. Relative to HE, PA was associated with faster 400-m walking speed among participants with MetS (P < 0.001) but not among those without MetS (P = 0.91), although the test for statistical interaction was marginally non-significant (P = 0.07). In contrast, no benefit of PA versus HE was observed on the SPPB score in either MetS subgroup. Conclusions: Among older adults at high risk for mobility disability, moderate-intensity physical activity conveys significant benefits in 400-m walking speed but not SPPB in those with, but not without, MetS. The LIFE physical activity program may be an effective strategy for maintaining or improving walking speed among vulnerable older adults with MetS. Trial registration: clinicaltrials.gov
AB - Background: In older adults, increases in physical activity may prevent decline in lower-extremity function, but whether the benefit differs according to metabolic syndrome (MetS) status is uncertain. We aim to investigate whether structured physical activity is associated with less decline in lower-extremity function among older adults with versus without MetS. Methods: We used data from the multicenter Lifestyle Interventions and Independence for Elders (LIFE) study to analyze 1535 sedentary functionally-vulnerable women and men, aged 70 to 89 years old, assessed every 6 months (February 2010–December 2013) for an average of 2.7 years. Participants were randomized to a structured, moderate-intensity physical activity intervention (PA; n = 766) or health education program (HE; n = 769). MetS was defined according to the 2009 multi-agency harmonized criteria. Lower-extremity function was assessed by 400-m walking speed and the Short Physical Performance Battery (SPPB) score. Results: 763 (49.7%) participants met criteria for MetS at baseline. Relative to HE, PA was associated with faster 400-m walking speed among participants with MetS (P < 0.001) but not among those without MetS (P = 0.91), although the test for statistical interaction was marginally non-significant (P = 0.07). In contrast, no benefit of PA versus HE was observed on the SPPB score in either MetS subgroup. Conclusions: Among older adults at high risk for mobility disability, moderate-intensity physical activity conveys significant benefits in 400-m walking speed but not SPPB in those with, but not without, MetS. The LIFE physical activity program may be an effective strategy for maintaining or improving walking speed among vulnerable older adults with MetS. Trial registration: clinicaltrials.gov
KW - Metabolic syndrome
KW - Physical activity intervention
KW - Randomized clinical trial
KW - Short physical performance battery
KW - Walking speed
UR - http://www.scopus.com/inward/record.url?scp=85104073777&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104073777&partnerID=8YFLogxK
U2 - 10.1016/j.exger.2021.111343
DO - 10.1016/j.exger.2021.111343
M3 - Article
C2 - 33848565
AN - SCOPUS:85104073777
SN - 0531-5565
VL - 150
JO - Experimental Gerontology
JF - Experimental Gerontology
M1 - 111343
ER -